MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1738.31%
Cash Ratio
770.02%
Debt to Asset Ratio
5.71%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
85,234
34,790
37,568
37,931
Short-term investments
104,748
88,253
108,129
124,666
Accounts receivable, net
-
-
0
0
Inventory
-
-
0
0
Prepaid expenses and other current assets
2,432
2,505
3,316
2,439
Total current assets
192,414
125,548
149,013
165,036
Property and equipment, gross
377
377
377
377
Accumulated depreciation
376
375
374
373
Property and equipment, net
1
2
3
4
Operating lease right-of-use assets
-
-
0
0
Other assets
1,579
1,681
1,814
1,977
Total assets
193,994
127,231
150,830
167,017
Accounts payable
1,105
1,745
917
1,633
Accrued liabilities
9,964
9,311
13,602
8,216
Operating lease liabilities, current portion
-
-
0
0
Total current liabilities
11,069
11,056
14,519
9,849
Operating lease liabilities, net of current portion
-
-
0
0
Other liabilities
-
-
0
0
Total liabilities
11,069
11,056
14,519
9,849
Common stock, 0.0001 par value 300,000,000 shares authorized 57,009,010 and 47,145,719 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
5
4
4
4
Additional paid-in capital
575,067
491,630
489,437
487,024
Accumulated other comprehensive (loss) income
-63
-15
120
139
Accumulated deficit
-392,084
-375,444
-353,250
-329,999
Total stockholders equity
182,925
116,175
136,311
157,168
Total liabilities and stockholders equity
193,994
127,231
150,830
167,017
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$104,748K (224.66%↑ Y/Y)Cash and cashequivalents$85,234K (-41.19%↓ Y/Y)Prepaid expenses andother current assets$2,432K (65.33%↑ Y/Y)Property and equipment,gross$377K (0.00%↑ Y/Y)Total current assets$192,414K (7.69%↑ Y/Y)Other assets$1,579K (-26.28%↓ Y/Y)Property and equipment,net$1K (-88.89%↓ Y/Y)Accumulated depreciation$376K (2.17%↑ Y/Y)Total assets$193,994K (7.28%↑ Y/Y)Total liabilities andstockholders equity$193,994K (7.28%↑ Y/Y)Total stockholdersequity$182,925K (6.31%↑ Y/Y)Total liabilities$11,069K (26.42%↑ Y/Y)Accumulated deficit-$392,084K (-25.57%↓ Y/Y)Accumulated othercomprehensive (loss) income-$63K (-800.00%↓ Y/Y)Additional paid-in capital$575,067K (18.74%↑ Y/Y)Total currentliabilities$11,069K (26.42%↑ Y/Y)Common stock, 0.0001par value...$5K (25.00%↑ Y/Y)Accrued liabilities$9,964K (83.94%↑ Y/Y)Accounts payable$1,105K (-66.91%↓ Y/Y)

Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics, Inc. (WHWK)